Low-dose aspirin for the prevention of atherothrombosis.
Patrono
Carlo
C
Department of Pharmacology, University of Rome La Sapienza, Rome, Italy. cpatrono@unich.it
García Rodríguez
Luis A
LA
Landolfi
Raffaele
R
Baigent
Colin
C
D001161:Arteriosclerosis / Q000517:prevention & control*; D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D051545:Cyclooxygenase 1 / Q000378:metabolism; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D004347:Drug Interactions; D004351:Drug Resistance; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D012306:Risk; D020521:Stroke / Q000517:prevention & control; D013927:Thrombosis / Q000517:prevention & control*; D013928:Thromboxane A2 / Q000096:biosynthesis / Q000502:physiology
D016861:Cyclooxygenase Inhibitors; D010975:Platelet Aggregation Inhibitors; D013928:Thromboxane A2; D051545:Cyclooxygenase 1; D001241:Aspirin